ServiceNow shares slide on slower cRPO growth; securities investigation underway
Oct 29, 2026, 8:01 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Combination of slower cRPO guidance, a sharp pre-market/market open decline, and ongoing securities investigation creates near-term downside risk; similar patterns followed past earnings surprises paired with legal uncertainty.
AI summary
What happened, with direct paths to the underlying reporting
NOW reported Q3 results with subscription revenue of $3.988B and cRPO growth of 21%, but guided Q4 cRPO growth to about 18.5%. The company raised its AI annual contract value target to $1.7B by year-end, the second increase this year. A securities-law investigation is underway, adding legal risk that could pressure the stock in the near term.
Q4 cRPO growth guided ~18.5%, down from 21%.
Q3 subscription revenue $3.988B; CC +20.5%; cRPO +21%.
AI ACV target raised to $1.7B by year-end (second increase).
Shares opened down ~20%, intraday down >25% amid a securities investigation.
Securities-law investigation into NOW potential violations underway;
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
ServiceNow posted Q3 revenue of about $4.11B, beating estimates, but adjusted EPS of $1.00 missed consensus of $1.02. The stock dropped ~18.5% pre-market, underscoring investor fo…
Analysts boosted ServiceNow (NOW) after Cantor Fitzgerald raised the target to $201 and maintained an Overweight stance, suggesting solid growth potential for NOW’s platform. With…
Bank of America raised NOW's price target to $180 from $150 and kept a Buy rating, citing AI-powered business automation as a growth catalyst. The note emphasizes NOW's workflow p…
Analysts raised ServiceNow targets and reinforced a positive stance, with Truist boosting NOW to $180 and Buy. The stock rose about 2.5% to $157 as investor interest persists, aid…